The Epidemiology of Imported Malaria and Transfusion Policy in 5 Nonendemic Countries

Transfusion Medicine Reviews

Volumn 29, Issue 3, 2015, Pages 162-171

  O'Brien, Sheila F ^a   Delage, Gilles ^b   Seed, Clive R ^c   Pillonel, Josiane ^d   Fabra, Cécile C ^e   Davison, Katy ^f,g   Kitchen, Alan ^g   Steele, Whitney R ^h   Leiby, David A ^h,i  

^a CANADIAN BLOOD SERVICES   (Canada)

^b HÉMA QUÉBEC   (Canada)

^c AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

^d INSTITUT DE VEILLE SANITAIRE   (France)

^e ETABLISSEMENT FRANÇAIS DU SANG   (France)

^f PUBLIC HEALTH ENGLAND   (United Kingdom)

^g NHS BLOOD AND TRANSPLANT   (United Kingdom)

^h HOLLAND LABORATORY   (United States)

ⁱ CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Blood donor; Epidemiology; Malaria; Policy

Indexed keywords

AUSTRALIA; BLOOD TRANSFUSION; CANADA; CARIBBEAN; DISEASE CONTROL; DISEASE TRANSMISSION; DONOR SELECTION; FRANCE; HEALTH CARE POLICY; HUMAN; MALARIA; MEXICO; NONHUMAN; PAPUA NEW GUINEA; PLASMODIUM FALCIPARUM; PLASMODIUM MALARIAE; PLASMODIUM VIVAX; REVIEW; RISK FACTOR; RISK REDUCTION; SAFETY; SOUTHEAST ASIA; TRAVEL; UNITED KINGDOM; UNITED STATES; ADVERSE EFFECTS; AFRICA; BLOOD DONOR; BLOOD SAFETY; ENDEMIC DISEASE; ENGLAND; HEALTH SURVEY; MIGRATION; PROCEDURES; STANDARDS; TRANSMISSION;

AFRICA; AUSTRALIA; BLOOD DONORS; BLOOD SAFETY; BLOOD TRANSFUSION; CANADA; DONOR SELECTION; EMIGRATION AND IMMIGRATION; ENDEMIC DISEASES; ENGLAND; FRANCE; HEALTH POLICY; HUMANS; MALARIA; PUBLIC HEALTH SURVEILLANCE; TRAVEL; UNITED STATES;

EID: 84930571552     PISSN: 08877963     EISSN: 15329496     Source Type: Journal    
DOI: 10.1016/j.tmrv.2015.03.004     Document Type: Review

References (54)

1. Steffan R., de Bernardis C., Banos A. Travel epidemiology-a global perspective. Int J Antimicrob Agents 2003, 21:89-95.
2. Leder K., Black J., O'Brien D., Greenwood Z., Kain K.C., Schwartz E., et al. Malaria in travellers: a review of the geosentinel surveillance network. CID 2004, 39:1104-1112.
3. World Health Organization World Malaria Report Available at:, [accessed July 7, 2014]. http://www.who.int/malaria/publications/world_malaria_report_2013/en/.
4. Mueller I., Galinski M.R., Baird J.K., Carlton J.M., Kochar D.K., Alonso P.L., et al. Key gaps in knowledge of Plasmodium vivax, a neglected human malaria parasite. Lancet 2009, 9:555-563.
5. Collins W.E., Jeffrey G.M. Plasmodium ovale: parasite and disease. Clin Microbiol Rev 2005, 18:570-581.
6. Collins W.E., Jeffrey G.M. Plasmodium malariae: parasite and disease. Clin Microbiol Rev 2007, 20:579-592.
7. Antinori S., Galimberti L., Milazzo L., Corbellino M. Biology of human malaria plasmodia including Plasmodium knowlesi. Mediterr J Hematol Infect Dis 2012, 4:e2012013.
8. Reesink H.W., Panzer S., Wendel S., Levi J.E., Ullum H., Ekblom-Kullberg S., et al. The use of malaria antibody tests in the prevention of transfusion-transmitted malaria. Vox Sang 2010, 98:468-478.
9. Garraud O., Assal A., Pelletier B., Danic B., Kerleguer A., David B., et al. Overview of revised measures to prevent malaria transmission by blood transfusion in France. Vox Sang 2008, 95:226-231.
10. Kitchen A.D., Lowe P.H.J., Lalloo K., Chiodini P.L. Evaluation of a malaria antibody assay for use in the screening of blood and tissue products for clinical use. Vox Sang 2004, 87:150-155.
11. Seed C.R., Kee G., Wong T., Law M., Ismay S. Assessing the safety and efficacy of a test-based, targeted donor screening strategy to minimize transfusion transmitted malaria. Vox Sang 2010, 98:e182-e192.
12. Leiby D.A., Nguyen M.L., Notari E.P. Impact of donor deferrals for malaria on blood availability in the United States. Transfusion 2008, 48:2222-2228.
13. Custer B., Johnson E.S., Sullivan S.D., Hazlet T.K., Ramsey S.D., Hirschler N.V., et al. Quantifying losses to the donated blood supply due to donor deferral and miscollection. Transfusion 2004, 44:1417-1426.
14. O'Brien S.F., Uzicanin S., Choquet K., Yi Q.L., Fan W., Goldman M. Impact of changes to policy for Mexican risk travel on Canadian blood donor deferrals. Blood Transfus 2013, 11:580-584.
15. Delage G., Dubuc S. Comparison of return rates of temporarily deferred donors with those of undeferred donors. Vox Sang 2008, 93(Suppl. 1):62.
16. World Tourism Organization Yearbook of tourism statistics: Data 2007-2011 2013, WTO, Madrid, Spain. 2013 Edition.
17. Center for Disease Control The Yellow Book: health information for international travel [accessed June 24, 2014]. http://wwwnc.cdc.gov/travel/page/yellowbook-2012-home.htm.
18. Population Reference Bureau 2011 World Population Data sheet Available at, [accessed Sept 25, 2012]. http://www.prb.org/.
19. Statistics Canada Immigration and Citizenship Available at:, [accessed June 24, 2014]. http://www12.statcan.gc.ca/census-recensement/2006/rt-td/immcit-eng.cfm.
20. Office of National Statistics Population by Nationality and Country of Birth (UK) Available at:, [accessed June 24, 2014]. http://www.ons.gov.uk/ons/taxonomy/index.html?nscl=Population+by+Nationality+and+Country+of+Birth.
21. Institut national de la statistique et des études économiques Insee, recensement de la population 2008, exploitation principale Table CD-MF2 Available at:, [accessed June 24, 2014]. http://www.insee.fr/fr/themes/detail.asp?reg_id=0&ref_id=pop-immigree-pop-etrangere-2008.
22. Australian Bureau of Statistics Cat. No. 2068.0-2006 Census Tables. Country of birth of persons (full classification list) by sex Available at:, [accessed June 24, 2014]. http://www.abs.gov.au/TableBuilder.
23. Census Bureau U.S. 2009 American Community Survey, B05002, "Place of Birth by Citizenship Status" C05006, "Place of Birth for the Foreign-Born Population" B05007, "Place of Birth by Year of Entry by Citizenship Status for the Foreign-Born Population" Available at:, [accessed June 24, 2014]. http://www.census.gov/population.
24. Eliades M.J., Shah S., Nguyen-Dinh P., Newman R.D., Barber A.M., Nguyen-Dinh P., et al. Malaria surveillance-United States, 2003. MMWR 2003, 54(SS-2). [Available at: http://www.cdc.gov/malaria/references_resources/mmwr.html (accessed June 24, 2014)].
25. Skarbinski J., James E.M., Causer L.M., Barber A.M., Mali S., Nguyen-Dinh P. Malaria surveillance-United States, 2004. MMWR 2004, 55(SS-4). [Available at: http://www.cdc.gov/malaria/references_resources/mmwr.html (accessed June 24, 2014)].
26. Thwing J., Skarbinski J., Newman R.D., Barber A.M., Mali S., Roberts J.M., et al. Malaria surveillance-United States, 2005. MMWR 2005, 56(SS-6). [Available at: http://www.cdc.gov/malaria/references_resources/mmwr.html (accessed June 24, 2014)].
27. Mali S., Steele S., Slutsker L., Arguin P.M. Malaria surveillance-United States, 2006. MMWR 2006, 57(SS-5). [Available at: http://www.cdc.gov/malaria/references_resources/mmwr.html (accessed June 24, 2014)].
28. Mali S., Steele S., Slutsker L., Arguin P.M. Malaria surveillance-United States, 2007. MMWR 2007, 58(SS-2). [Available at: http://www.cdc.gov/malaria/references_resources/mmwr.html (accessed June 24, 2014)].
29. Mali S., Steele S., Slutsker L., Arguin P.M. Malaria surveillance-United States, 2008. MMWR 2008, 59(SS-7). [Available at: http://www.cdc.gov/malaria/references_resources/mmwr.html (accessed June 24, 2014)].
30. Mali S., Tan K.R., Arguin P.M. Malaria surveillance-United States, 2009. MMWR 2009, 60(3). [Available at: http://www.cdc.gov/malaria/references_resources/mmwr.html (accessed June 24, 2014)].
31. Mali S., Kachur S.P., Arguin P.M. Malaria surveillance-United States, 2010. MMWR 2010, 61(2). [Available at: http://www.cdc.gov/malaria/references_resources/mmwr.html (accessed June 24, 2014)].
32. Cullen K.A., Arguin P.M. Malaria surveillance-United States, 2011. MMWR 2011, 62(5). [Available at: http://www.cdc.gov/mmwr/pdf/ss/ss6205.pdf (accessed June 24, 2014)].
33. Rapport CNR Paludisme Institut de veille sanitaire Available at:, [accessed June 24, 2014]. http://www.cnrpalu-france.org/docs/rapport_activites_cnr_paludisme_2011.pdf.
34. Wright P., Fitzsimmons G.J., Johansen C.A., Whelan P.I., National Arbovirus, Malaria Advisory Committee Arboviral diseases and malaria in Australia, 2009-10: annual report of the National Arbovirus and Malaria Advisory Committee. CDI 2012, 36:70-81. [Available at: http://www.health.gov.au/internet/main/publishing.nsf/Content/cda-arboanrep.htm (accessed June 24, 2014)].
35. Health Protection Report Vol. 6 No. 17 Published 27 April 2012 Available at:, [accessed June 24, 2014]. http://www.hpa.org.uk/HPR/archives/2012/HPR1712.pdf.
36. Toronto Public Health Communicable diseases in Toronto 2011 Available at:, [accessed June 24, 2014]. http://www.toronto.ca/health/cdc/communicable_disease_surveillance/statistics_and_reports/annual_reports/index.htm.
37. Kitchen A.D., Barbara J.A.J., Hewitt P.E. Documented cases of post-transfusion malaria occurring in England: a review in relation to current and proposed donor-selection guidelines. Vox Sang 2005, 89:77-80.
38. Maire F., Gallian P., Houze S., Resche E., Corbi C., Ribon N., et al. A propos d'un cas de paludisme post-transfusionnel. Proceedings of the Journées nationales d'infectiologie, Clermont-Ferrand, 12-14 June, 2013 2013.
39. Lab 21 Lab 21 Malaria total antibody EIA Available at:, [accessed July 7, 2014]. http://www.trinitybiotech.com/Product%20Documents/60127-29%20EN.pdf.
40. Kitchen A.D., Chiodini P.L. Malaria and blood transfusion. Vox Sang 2006, 90:77-84.
41. Seed C.R., Kitchen A., Davis T.M.E. The current status and potential role of laboratory testing to prevent transfusion-transmitted malaria. Trans Med Rev 2005, 19:229-240.
42. Nguyen M.L., Goff T., Gibble J., Steele W.R., Leiby D.A. Analyzing actual risk in malaria-deferred donors through selective serologic testing. Transfusion 2013, 53:1736-1743.
43. Chiodini P.L., Hartley S., Hewitt P.E., Barbara J.A., Lalloo K., Blish J., et al. Evaluation of a malaria antibody ELISA and its value in reducing potential wastage of red cell donations from blood donors exposed to malaria, with a note on a case of transfusion-transmitted malaria. Vox Sang 1997, 73:143-148.
44. Faddy H.M., Seed C.R., Faddy M.J., Flower R.L., Harley R.J. Malaria antibody persistence correlates with duration of exposure. Vox Sang 2012, 104:292-298.
45. Brouwer E.E., van Hellemond J.J., van Genderen P.J., Slot E., van Lieshout L., Visser L.G., et al. A case report of transfusion-transmitted Plasmodium malariae from an asymptomatic non-immune traveller. Malar J 2013, 12:439-444.
46. Battle K.E., Karhunen M.S., Bhatt S., Gething P.W., Howes R.E., Golding N., et al. Geographical variation in Plasmodium vivax relapse. Malar J 2014, 13:144. [http://www.malariajournal.com/content/13/1/144.
47. Spencer B., Steele W., Custer B., Kleinman S., Cable R., Wilkinson S., et al. Risk of malaria in United States donors deferred for travel to malaria-endemic areas. Transfusion 2009, 49:2335-2345.
48. Spencer B., Kleinman S., Custer B., Cable R., Wilkinson S.L., Steele W., et al. Deconstructing the risk for malaria in United States donors deferred for travel to Mexico. Transfusion 2011, 51:2398-2410.
49. Wilson K. A framework for applying the precautionary principle to transfusion safety. Trans Med Rev 2011, 25:177-183.
50. Strickland J.F., Roberts A.N., Williams V. Transfusion-induced malaria in Victoria. Med J Aust 1992, 157:499-500.
51. Seed C.R., Coughlin J.T., Pickworth A.M., Harley R.J., Keller A.J. Relapsing vivax malaria despite chemoprophylaxis in two blood donors who had travelled to Papua New Guinea. Med J Aust 2010, 192:471-473.
52. Slinger R., Giulivi A., Bodie-Collins M., Hindieh F., St John R., Sher G., et al. Transfusion-transmitted malaria in Canada. Can Med Assoc J 2001, 164:377-379.
53. Mungai M., Tegtmeir G., Chamberland M., Parise M. Transfusion-transmitted malaria in the United States from 1963 through 1999. N Engl J Med 2001, 344:1973-1978.
54. Kitchen A.D., Chiodini P.L., Tossell J. Detection of malarial DNA in blood donors-evidence of persistent infection. Vox Sang 2014, 107:123-131.